Enhancing the value delivered by the statistician throughout drug discovery and development: putting statistical science into regulated pharmaceutical innovation
Gg. Enas et Js. Andersen, Enhancing the value delivered by the statistician throughout drug discovery and development: putting statistical science into regulated pharmaceutical innovation, STAT MED, 20(17-18), 2001, pp. 2697-2708
Citations number
2
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research General Topics
With the dawn of the 21st century, the pharmaceutical industry faces a dram
atically different constellation of business and scientific predictors of s
uccess than those of just a few years ago. Significant advances in science
at the genetic, molecular and cellular levels, combined with progress demon
strated around the globe with drug regulations, have increased business and
competitive opportunities. This has occurred in search of better and cheap
er medicines that reach patients with unmet medical needs as quickly as pos
sible. Herein lie new opportunities for those who can help business and reg
ulatory leaders make good decisions about drug development and market autho
rization as quickly and efficiently as possible in the presence of uncertai
nty. The statistician is uniquely trained and qualified to render such valu
e. We show how the statistician can contribute to the process of drug innov
ation from the very early stages of drug discovery until patients, payers a
nd regulators are satisfied. Indeed, the very nature of regulated innovatio
n demands that efficient and effective processes are implemented which yiel
d the right information for good decision making. The statistician can take
the lead in setting a strategy that directs such processes in the directio
n of greatest value. This demands skills that enable one to identify import
ant sources of variability and uncertainty and then leverage those skills t
o make decisions. If such decisions call for more information, then the sta
tistician can render experimental designs which generate the right informat
ion needed to make the decision in an efficient, timely manner. To add valu
e to the enterprise, statisticians will have to become more intimately asso
ciated with business and regulatory decisions by building on their traditio
nal roles (for example, numerical analyst, tactician) and unique skill sets
(for example, analysis, computation, logical thought and work process, pre
cision, accuracy). Business and regulatory savvy, coupled with excellent co
mmunication and interpersonal skills, will allow statisticians to help crea
te the knowledge needed to drive success in the future. Copyright (C) 2001
John Wiley & Sons, Ltd.